ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 100 filers reported holding ANTARES PHARMA INC in Q2 2018. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $1,199,000 | +6.1% | 275,000 | 0.0% | 0.19% | -2.1% |
| Q1 2021 | $1,130,000 | +3.0% | 275,000 | 0.0% | 0.19% | +2.1% |
| Q4 2020 | $1,097,000 | +47.6% | 275,000 | 0.0% | 0.19% | +24.5% |
| Q3 2020 | $743,000 | +1.9% | 275,000 | 0.0% | 0.15% | -2.6% |
| Q2 2020 | $729,000 | +16.8% | 275,000 | 0.0% | 0.16% | -3.1% |
| Q1 2020 | $624,000 | -51.7% | 275,000 | 0.0% | 0.16% | -48.2% |
| Q4 2019 | $1,293,000 | +40.5% | 275,000 | 0.0% | 0.31% | +19.3% |
| Q3 2019 | $920,000 | +1.7% | 275,000 | 0.0% | 0.26% | +7.5% |
| Q2 2019 | $905,000 | +8.6% | 275,000 | 0.0% | 0.24% | +23.0% |
| Q1 2019 | $833,000 | +6.7% | 275,000 | 0.0% | 0.20% | +31.5% |
| Q4 2018 | $781,000 | -15.5% | 275,000 | 0.0% | 0.15% | +0.7% |
| Q3 2018 | $924,000 | +30.1% | 275,000 | 0.0% | 0.15% | +20.3% |
| Q2 2018 | $710,000 | +17.4% | 275,000 | 0.0% | 0.12% | +8.8% |
| Q1 2018 | $605,000 | +10.6% | 275,000 | 0.0% | 0.11% | +7.6% |
| Q4 2017 | $547,000 | -38.6% | 275,000 | 0.0% | 0.10% | -45.6% |
| Q3 2017 | $891,000 | +0.6% | 275,000 | 0.0% | 0.19% | -4.9% |
| Q2 2017 | $886,000 | +13.4% | 275,000 | 0.0% | 0.20% | +4.6% |
| Q1 2017 | $781,000 | +21.8% | 275,000 | 0.0% | 0.19% | +10.9% |
| Q4 2016 | $641,000 | +38.7% | 275,000 | 0.0% | 0.18% | +29.6% |
| Q3 2016 | $462,000 | +883.0% | 275,000 | +896.8% | 0.14% | +694.1% |
| Q3 2015 | $47,000 | -17.5% | 27,587 | 0.0% | 0.02% | -10.5% |
| Q2 2015 | $57,000 | -25.0% | 27,587 | -2.0% | 0.02% | -26.9% |
| Q1 2015 | $76,000 | +5.6% | 28,137 | 0.0% | 0.03% | 0.0% |
| Q4 2014 | $72,000 | +41.2% | 28,137 | 0.0% | 0.03% | +36.8% |
| Q3 2014 | $51,000 | -62.2% | 28,137 | -44.3% | 0.02% | -61.2% |
| Q2 2014 | $135,000 | -23.7% | 50,550 | 0.0% | 0.05% | -30.0% |
| Q1 2014 | $177,000 | -21.7% | 50,550 | 0.0% | 0.07% | -23.1% |
| Q4 2013 | $226,000 | +10.2% | 50,550 | 0.0% | 0.09% | +1.1% |
| Q3 2013 | $205,000 | -2.4% | 50,550 | 0.0% | 0.09% | -11.8% |
| Q2 2013 | $210,000 | – | 50,550 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 3,096,355 | $8,422,000 | 5.18% |
| JW Asset Management, LLC | 1,920,524 | $5,224,000 | 3.85% |
| Healthcare Value Capital, LLC | 250,000 | $680,000 | 2.64% |
| ARMISTICE CAPITAL, LLC | 10,300,000 | $28,016,000 | 2.12% |
| Broadfin Capital, LLC | 3,444,147 | $9,368,000 | 1.23% |
| PERKINS CAPITAL MANAGEMENT INC | 409,000 | $1,112,000 | 0.86% |
| MYCIO WEALTH PARTNERS, LLC | 1,896,500 | $5,158,000 | 0.48% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 1,012,600 | $2,754,000 | 0.22% |
| FALCON POINT CAPITAL, LLC | 130,200 | $354,000 | 0.21% |
| Brown Advisory Securities, LLC | 275,000 | $781,000 | 0.15% |